info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143492 |
| CAS No | NA |
| Mol.F. | C14H16N6O2 |
| Mol.Wt. | 300.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143493 |
| CAS No | NA |
| Mol.F. | C8H11N3O3S |
| Mol.Wt. | 229.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143494 |
| CAS No | 53743-85-4 |
| Mol.F. | C10H14N2O · HCl |
| Mol.Wt. | 214.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143496 |
| CAS No | NA |
| Mol.F. | C19H24N6O3 |
| Mol.Wt. | 384.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143497 |
| CAS No | NA |
| Mol.F. | C21H29N7O2S |
| Mol.Wt. | 443.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143498 |
| CAS No | NA |
| Mol.F. | C16H25N5O4S |
| Mol.Wt. | 383.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143499 |
| CAS No | 120-22-9 |
| Mol.F. | C10H14N2O |
| Mol.Wt. | 178.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143500 |
| CAS No | NA |
| Mol.F. | C8H9N3O5 |
| Mol.Wt. | 227.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143501 |
| CAS No | NA |
| Mol.F. | C22H18N4O5 |
| Mol.Wt. | 418.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143502 |
| CAS No | NA |
| Mol.F. | C22H18N4O5 |
| Mol.Wt. | 418.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143503 |
| CAS No | NA |
| Mol.F. | C22H18N4O7 |
| Mol.Wt. | 450.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143504 |
| CAS No | NA |
| Mol.F. | C22H18N4O7 |
| Mol.Wt. | 450.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143505 |
| CAS No | NA |
| Mol.F. | C22H18N4O7 |
| Mol.Wt. | 450.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143506 |
| CAS No | NA |
| Mol.F. | C22H18N4O6 |
| Mol.Wt. | 434.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143507 |
| CAS No | NA |
| Mol.F. | C21H18ClN5O5 |
| Mol.Wt. | 455.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143508 |
| CAS No | NA |
| Mol.F. | C10H10ClN3O3 |
| Mol.Wt. | 255.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
